Jade Biosciences, Inc.
JBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25 | -$32 | – | -$5 |
| Dep. & Amort. | $0 | $0 | – | $0 |
| Deferred Tax | $0 | $0 | – | $0 |
| Stock-Based Comp. | $0 | $0 | – | $0 |
| Change in WC | -$1 | $4 | – | -$7 |
| Other Non-Cash | $4 | -$9 | – | $1 |
| Operating Cash Flow | -$22 | -$37 | – | -$11 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | – | $0 |
| Net Acquisitions | $0 | $0 | – | $0 |
| Inv. Purchases | -$149 | $0 | – | $0 |
| Inv. Sales/Matur. | $0 | -$13 | – | $13 |
| Other Inv. Act. | -$0 | $0 | – | $0 |
| Investing Cash Flow | -$149 | -$13 | – | $13 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | – | $0 |
| Stock Issued | $0 | $190 | – | $1 |
| Stock Repurch. | $0 | $0 | – | $0 |
| Dividends Paid | $0 | $0 | – | $0 |
| Other Fin. Act. | $0 | $0 | – | $0 |
| Financing Cash Flow | $0 | $191 | – | $1 |
| Forex Effect | -$0 | $36 | – | $0 |
| Net Chg. in Cash | -$171 | $177 | – | $3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $221 | $44 | – | $31 |
| End Cash | $50 | $221 | – | $34 |
| Free Cash Flow | -$22 | -$37 | – | -$11 |